🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
An evaluation of the long term safety of tanezumab when administered by sub...
Status
Terminated
Location
Triwest Research Associates
Start Date
2010-06-15
Trial ID
NCT01127893
The purpose of this study is to evaluate the efficacy and safety of multipl...
Status
Completed
Location
Pinnacle Research Group, LLC
Start Date
2009-06-15
Trial ID
NCT00876187
This study will investigate the safety of three fixed dose levels of tanezu...
Status
Terminated
Location
Mobile Diagnostic Center
Start Date
2009-11-17
Trial ID
NCT00994890
Treatments Being Tested
The hypothesis of this study is that subcutaneous administration of tanezum...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-11
Trial ID
NCT00788294
Test the efficacy and safety of 2 doses of tanezumab compared with naproxen...
Status
Completed
Location
Greystone Medical Research, LLC
Start Date
2009-06-09
Trial ID
NCT00863304
Treatments Being Tested
Tanezumab reduces pain of osteoarthritis without affecting how nerve impuls...
Status
Terminated
Location
NEA Baptist Clinic
Start Date
2009-05-18
Trial ID
NCT00863772
Test the efficacy and safety of 3 doses in Osteoarthritis of the knee in pa...
Status
Completed
Location
Arizona Research Center, Inc.
Start Date
2008-09-15
Trial ID
NCT00733902
Tanezumab, administered for up to 1 1/2 years, reduces the pain of osteoart...
Status
Terminated
Location
Jem Research, LLC
Start Date
2010-02-15
Trial ID
NCT00960804
This study will investigate the efficacy and safety of tanezumab 5 mg and 1...
Status
Completed
Location
Central Alabama Research
Start Date
2015-08-18
Trial ID
NCT02528253
The purpose of this study is to compare the long-term joint safety and effi...
Status
Completed
Location
Central Alabama Research
Start Date
2015-07-21
Trial ID
NCT02528188
Treatments Being Tested